Pharmaceutical stocks likely pick up in coming quarters

Pharmaceutical stocks will likely get a boost in the coming quarters on their defensive nature and expectations for visible outcomes of R&D new drug projects, bolstered by potential sales of generics over Novarsc and Amaryl, analysts said.

A pharmaceutical report, released by Hanyang Securities Co., on October 4, showed that the Korea Composite Stock Price index in September, the barometer o...